The Central Consumer Protection Authority (CCPA) has imposed a Rs 3 lakh penalty on fitness firm VLCC Limited for running ...

IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...

LASIK is marketed as a simple procedure, but for some, it's anything but. Patients explain the realities of living with dry ...

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

In the spring of 2022, Marla Neise's brother noticed she was experiencing memory issues and confusion at the company where they work. "I couldn't balance a checkbook, put things in an order or stay ...

EnVVeno Medical has been told by the Food and Drug Administration that VenoValve, a surgical replacement venous valve for treating severe deep chronic venous insufficiency, isn't approvable.

Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby ...

Radiation is a bad thing that we don’t want to be exposed to, or so the conventional wisdom goes. We’re most familiar with it in the context of industrial risks and the stories of ...